MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Motor and non-motor correlates of APOE-ε4 mediated cerebrospinal fluid concentrations of biomarkers of amyloidogenesis and neurodegeneration in dementia with Lewy bodies compared with Alzheimer’s dementia and healthy controls

F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)

Meeting: 2018 International Congress

Abstract Number: 63

Keywords: Dementia, Dementia with Lewy bodies (DLB), Parkinsonism

Session Information

Date: Saturday, October 6, 2018

Session Title: Cognitive Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To study associations of cerebrospinal fluid biomarkers of amyloidogenesis and neurodegeneration with motor and non-motor aspects of daily experiences in dementia with Lewy bodies (DLB) compared with Alzheimer’s dementia (AD) and cognitively healthy people.

Background: Motor and non-motor aspects of daily experiences may reflect amyloidogenesis and neurodegeneration in dementia syndromes.

Methods: Consecutive outpatients with probable DLB (fourth consensus report of the DLB Consortium) were paired with outpatients with late-onset AD (National Institute on Aging – Alzheimer’s Association workgroups) by gender, Clinical Dementia Rating (CDR) and Mini-Mental State Examination scores, and with cognitively healthy controls by gender and age (±1 year). Genotyping was undertaken with TaqMan® Real-Time Polymerase Chain Reactions for APOE (rs7412 & rs429358). Cerebrospinal fluid concentrations of amyloid (Aβ42, Aβ40, Aβ38), α-synuclein, and neurofilament light (NFL) were assessed by enzyme-linked immunosorbent assays (ELISA), and correlated with the Schwab and England Scale (S&E), the Movement Disorder Society – Unified Parkinson’s Disease Rating Scale (MDS-UPDRS parts I/II/III), and the Hoehn and Yahr stages (H&Y).

Results: Overall, 27 participants with DLB (78.48±9.0 years-old, CDR sum-of-boxes 11.00±3.8, eleven APOE-ε4 carriers) were paired with 27 participants with AD (81.00±5.8 years-old, CDR sum-of-boxes 10.46±3.9, twelve APOE-ε4 carriers) and 27 controls (78.48±8.7 years-old, CDR sum-of-boxes 0.41±0.8, four APOE-ε4 carriers). Associations for APOE-ε4 carriers (p<0.001): Aβ42/Aβ40 ratio and Aβ38 associated with S&E in AD; α-synuclein inversely associated with S&E in DLB; NFL inversely associated with S&E in DLB and AD; Aβ38 and α-synuclein inversely associated with MDS-UPDRS-I in DLB, and inversely associated with MDS-UPDRS II & III in AD; NFL associated with MDS-UPDRS II & III in AD. Associations for APOE-ε4 non-carriers (p<0.001): α-synuclein associated with S&E in AD; NFL inversely associated with S&E for all groups; Aβ42/Aβ40 ratio inversely associated with MDS-UPDRS-II for all groups, and inversely associated with H&Y in DLB; Aβ38 and α-synuclein inversely associated with MDS-UPDRS II & III and H&Y in DLB and AD; NFL associated with MDS-UPDRS I & II & III for all groups; NFL associated with H&Y in DLB.

Conclusions: Amyloidogenesis and neurodegeneration differentially affect motor and non-motor features in dementia syndromes.

To cite this abstract in AMA style:

F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti. Motor and non-motor correlates of APOE-ε4 mediated cerebrospinal fluid concentrations of biomarkers of amyloidogenesis and neurodegeneration in dementia with Lewy bodies compared with Alzheimer’s dementia and healthy controls [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/motor-and-non-motor-correlates-of-apoe-%ce%b54-mediated-cerebrospinal-fluid-concentrations-of-biomarkers-of-amyloidogenesis-and-neurodegeneration-in-dementia-with-lewy-bodies-compared-with-alzheimer/. Accessed May 19, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/motor-and-non-motor-correlates-of-apoe-%ce%b54-mediated-cerebrospinal-fluid-concentrations-of-biomarkers-of-amyloidogenesis-and-neurodegeneration-in-dementia-with-lewy-bodies-compared-with-alzheimer/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley